*nlm.life
			PubMed Journals: J Med Virol

  Source:		PMID: 32056249


    		J Med Virol. 2020 Feb 13. doi:
     		10.1002/jmv.25709. [Epub ahead of print]

			Overlapping and discrete aspects of the
			pathology and pathogenesis of the emerging
			human pathogenic coronaviruses SARS-CoV,
			MERS-CoV, and 2019-nCoV.

			Liu J(1)(2), Zheng X(1)(2), Tong Q(1), Li W(1),
			Wang B(1)(2), Sutter K(3)(2), Trilling M(3)(2), Lu
			M(3)(2), Dittmer U(3)(2), Yang D(1)(2).

			Author Information
			(1) Department of Infectious Diseases, Union
			Hospital, Tongji Medical College,
			Huazhong University of Science and Technology,
			Wuhan, Hubei, China.
			(2) Joint International Laboratory of Infection
			and Immunity, Huazhong University of Science
			and Technology, Wuhan, Hubei, China.
			(3) Institute for Virology, University Hospital of
			Essen, University of Duisburg-Essen, Essen,
			Germany.

			First reported from Wuhan, The People's
			Republic of China, on 31 December 2019, the
			ongoing outbreak of a novel coronavirus
			(2019-nCoV) causes great global concerns.
			Based on the advice of the International Health
			Regulations Emergency Committee and the
			fact that to date 24 other countries also
			reported cases, the WHO Director-General
			declared that the outbreak of 2019-nCoV
			constitutes a Public Health Emergency of
			International Concern on 30 January 2020.
			Together with the other two highly pathogenic
			coronaviruses, the
			severe acute respiratory syndrome coronavirus
			(SARS-CoV) and
			Middle East respiratory syndrome coronavirus
			(MERS-CoV), 2019-nCov and other yet to be
			identified coronaviruses pose a global threat to
			public health. In this mini-review, we provide a
			brief introduction to the pathology and
			pathogenesis of SARS-CoV and MERS-CoV
			and extrapolate this knowledge to the newly
			identified 2019-nCoV.

			©2020 Wiley Periodicals, Inc.

			DOI: 10.1002/jmv.25709 PMID: 32056249

     			                         Tweet       Print